Skip to main content
Clinical Trials/ACTRN12620001131943
ACTRN12620001131943
Completed
Phase 4

Investigating the post-operative opioid use of patients who received intraoperative methadone compared with those who received conventional potent opioids during laparoscopic gynaecological surgery - a double blind randomised controlled trial.

niversity of New South Wales0 sites69 target enrollmentOctober 30, 2020

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of New South Wales
Enrollment
69
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 30, 2020
End Date
May 18, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Adults undergoing general surgery laparoscopy as well as gynaecology laparoscopy at Albury and Wodonga Hospitals
  • \-Planned same\-day discharge
  • \-Able to speak and read English

Exclusion Criteria

  • \-Morbid obesity
  • \-Obstructive sleep apnoea, treated with CPAP, or diagnosed but untreated
  • \-Significant renal or liver dysfunction
  • \-Pregnant or breastfeeding women
  • \-Preoperative opioid dependence
  • \-Known or suspected allergy to methadone
  • \-Anaesthetist wish to avoid methadone administration for any reason
  • \-Undergoing laparoscopic bowel resection or laparoscopic nephrectomy
  • \-Undergoing emergency laparoscopic operations (e.g. appendicectomy, ectopic pregnancy)
  • \-Patients with long QT syndrome, and any on whom a preop ECG reveals a long QT interval

Outcomes

Primary Outcomes

Not specified

Similar Trials